CONMED Net Worth

CONMED Net Worth Analysis

CONMED Target Price Consensus

CONMED Target Price Projection

CONMED's current and average target prices are 50.95 and 65.67, respectively. The current price of CONMED is the price at which CONMED is currently trading. On the other hand, CONMED's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on CONMED and the information provided on this page.

Know CONMED's Top Institutional Investors

Note, although CONMED's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow CONMED's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.58 B.

Project CONMED's profitablity

The company has Profit Margin (PM) of 0.09 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate CONMED's management efficiency

CONMED has return on total asset (ROA) of 0.0414 % which means that it generated a profit of $0.0414 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1296 %, meaning that it created $0.1296 on every $100 dollars invested by stockholders. CONMED's management efficiency ratios could be used to measure how well CONMED manages its routine affairs as well as how well it operates its assets and liabilities. As of July 28, 2025, Return On Tangible Assets is expected to decline to 0.08. In addition to that, Return On Capital Employed is expected to decline to 0.09. At present, CONMED's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 122.2 M, whereas Intangible Assets are forecasted to decline to about 342.3 M.

CONMED Corporate Filings

CONMED time-series forecasting models is one of many CONMED's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CONMED's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

CONMED Earnings Estimation Breakdown

The calculation of CONMED's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of CONMED is estimated to be 1.11 with the future projection ranging from a low of 1.1 to a high of 1.14. Please be aware that this consensus of annual earnings estimates for CONMED is based on EPS before non-recurring items and includes expenses related to employee stock options.

CONMED Earnings Projection Consensus

CONMED Earnings History

Earnings estimate consensus by CONMED analysts from Wall Street is used by the market to judge CONMED's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only CONMED's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods. At present, CONMED's Earnings Yield is projected to slightly decrease based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.16, whereas Retained Earnings Total Equity is forecasted to decline to about 467.3 M. As of July 28, 2025, Common Stock Shares Outstanding is expected to decline to about 26.2 M. The current year's Net Loss is expected to grow to about (68.9 M).

Hype Prediction Low Estimated High 47.82 50.94 54.06 Details

Intrinsic Valuation Low Real High 45.86 59.09 62.21 Details

Naive Forecast Low Next High 47.76 50.88 54.00 Details

6 Analysts Consensus Low Target High 59.76 65.67 72.89 Details

Note that many institutional investors and large investment bankers can move markets due to the volume of CONMED assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards CONMED. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving CONMED's stock price in the short term.

CONMED Earnings per Share Projection vs Actual

Actual Earning per Share of CONMED refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering CONMED predict the company's earnings will be in the future. The higher the earnings per share of CONMED, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

CONMED Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as CONMED, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of CONMED should always be considered in relation to other companies to make a more educated investment decision.

CONMED Quarterly Analyst Estimates and Surprise Metrics

CONMED Corporate Directors

When determining whether CONMED is a strong investment it is important to analyze CONMED's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CONMED's future performance. For an informed investment choice regarding CONMED Stock, refer to the following important reports:

How To Invest In CONMED Details

Is CONMED Stock a good investment? Details

What is CONMED's Net Worth? Details

Largest Health Care Equipment & Supplies Companies View

Largest Health Care Equipment & Services Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details